إعلان
إعلان

TECH

TECH logo

Bio-Techne Corp.

63.59
USD
برعاية
-1.46
-2.25%
٠٨ يناير, ١٠:٣٧ UTC -5
مفتوح

تقارير أرباح TECH

النسبة الإيجابية المفاجئة

TECH تفوق 24 من 39 آخر التقديرات.

62%

التقرير التالي

بيانات التقرير القادم
٠٣ فبراير ٢٠٢٦
Estimate for Q2 26 (Revenue/ EPS)
$295.99M
/
$0.44
التغير الضمني من Q1 26 (Revenue/ EPS)
+3.29%
/
+4.76%
التغير الضمني من Q2 25 (Revenue/ EPS)
+0.28%
/
+4.76%

Bio-Techne Corp. earnings per share and revenue

On ٠٥ نوفمبر ٢٠٢٥, TECH reported earnings of 0.42 USD per share (EPS) for Q1 26, missing the estimate of 0.42 USD, resulting in a -2.03% surprise. Revenue reached 286.56 مليون, compared to an expected 297.05 مليون, with a -3.53% difference. The market reacted with a -1.90% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 16 المحللين forecast an EPS of 0.44 USD, with revenue projected to reach 295.99 مليون USD, implying an زيادة of 4.76% EPS, and زيادة of 3.29% in Revenue from the last quarter.
الأسئلة الشائعة
For Q1 2026, Bio-Techne Corp. reported EPS of $0.42, missing estimates by -2.03%, and revenue of $286.56M, -3.53% below expectations.
The stock price moved down -1.9%, changed from $61.10 before the earnings release to $59.94 the day after.
The next earning report is scheduled for ٠٣ فبراير ٢٠٢٦.
Based on 16 المحللين, Bio-Techne Corp. is expected to report EPS of $0.44 and revenue of $295.99M for Q2 2026.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان